The Tennessee Department of Health (TDH) is warning the public about a newly-identified synthetic opioid, cychlorphine, that has been associated with more than 30 overdose ...

Lofexidine is administered during the period of peak withdrawal symptoms. The Food and Drug Administration (FDA) has approved Lofexidine Tablets 0.18mg, the first generic of Lucemyra. Lofexidine is a ...

A local health expert is raising awareness about opioid overdose prevention, the risks of an overdose during spring break, ...

BXCL501 demonstrated clinical benefits and favorable tolerability profile for treatment of opioid withdrawal symptoms Results from this NIDA-funded study support potential future development of ...

EVERETT, Wash. — The Everett Fire Department’s Emergency Medical Services Division (EMS) has launched a new pilot programto allow paramedics to administer buprenorphine, to help with opiate withdrawal ...

Recovery from opiate addiction is not an easy path. For those attempting to stop, withdrawal symptoms can feel like a full-body rebellion; nausea and muscle aches, chills, anxiety, insomnia, and mood ...

After years of hiding his substance abuse, Ken Rideout finally confessed to his wife. It was the start of a difficult and rewarding journey, which led to athletic success in his 50s ...

Marijuana helps people with substance misuse disorders stay off opioids or reduce their use, maintain treatment, and manage withdrawal symptoms, a new federally funded study finds. Researchers at the ...

The device, which is cleared by the FDA for withdrawal mitigation from opioid use disorder, works by abating severe symptoms such as stomach aches, back aches, sweats, and the inability to keep food ...

Weekly injectable buprenorphine is more effective than daily doses for treating opioid use disorder in pregnancy, with higher ...